Research & Literature

Migraine aura symptoms: Duration, succession and temporal relationship to headache.

Viana M, Linde M, Sances G, et al.

Cephalalgia : an international journal of headache 2016; (36(5)):413-21 doi:10.1177/0333102415593089.

Headache disorders and public ill-health in India: prevalence estimates in Karnataka State.

Kulkarni GB, Rao GN, Gururaj G, et al.

The journal of headache and pain 2015; (16()):67 doi:10.1186/s10194-015-0549-x.

Procedural Headache Medicine in Neurology Residency Training: A Survey of US Program Directors.

Robbins MS, Robertson CE, Ailani J, et al.

Headache 2016; (56(1)):79-85 doi:10.1111/head.12695.

Visual evoked potentials in subgroups of migraine with aura patients.

Coppola G, Bracaglia M, Di Lenola D, et al.

The journal of headache and pain 2015; (16()):92 doi:10.1186/s10194-015-0577-6.

Analysis of Trigger Factors in Episodic Migraineurs Using a Smartphone Headache Diary Applications.

Park JW, Chu MK, Kim JM, et al.

PloS one 2016; (11(2)):e0149577 doi:10.1371/journal.pone.0149577.

How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management?

Ashina S, Olesen J, Lipton RB

Current pain and headache reports 2016; (20(12)):66 doi:10.1007/s11916-016-0599-z.

Comment: Headache medicine as an emerging subspecialty-Irony and reality.

Robbins MS

Neurology 2017; (88(13)):e124 doi:10.1212/WNL.0000000000003774.

Trigger Factors in Childhood Migraine: A Prospective Clinic-Based Study From North of France.

Solotareff L, Cuvellier JC, Duhamel A, et al.

Journal of child neurology 2017; (32(8)):754-758 doi:10.1177/0883073817705251.

Prophylaxis of migraine headaches with riboflavin: A systematic review.

Thompson DF, Saluja HS

Journal of clinical pharmacy and therapeutics 2017; (42(4)):394-403 doi:10.1111/jcpt.12548.

The premonitory phase: A crucial stage in migraine.

Gago-Veiga AB, Vivancos J, Sobrado M

Neurologia 2021; (36(4)):298-304 doi:10.1016/j.nrl.2017.09.014.

Association of neurologist care with headache expenditures: A population-based, longitudinal analysis.

Ney JP, Sico JJ, Klein BC, et al.

Cephalalgia : an international journal of headache 2018; (38(12)):1876-1884 doi:10.1177/0333102418762572.

CGRP as the target of new migraine therapies - successful translation from bench to clinic.

Edvinsson L, Haanes KA, Warfvinge K, Krause DN

Nature reviews. Neurology 2018; (14(6)):338-350 doi:10.1038/s41582-018-0003-1.

Recent Insights in Migraine With Aura: A Narrative Review of Advanced Neuroimaging.

Russo A, Silvestro M, Tessitore A, Tedeschi G

Headache 2019; (59(4)):637-649 doi:10.1111/head.13512.

Migraine patients' journey until a tertiary headache center: an observational study.

Peres MFP, Swerts DB, de Oliveira AB, Silva-Neto RP

The journal of headache and pain 2019; (20(1)):88 doi:10.1186/s10194-019-1039-3.

A prospective study on osmophobia in migraine versus tension-type headache in a large series of attacks.

Terrin A, Mainardi F, Lisotto C, et al.

Cephalalgia : an international journal of headache 2020; (40(4)):337-346 doi:10.1177/0333102419877661.

Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial.

Seng EK, Singer AB, Metts C, et al.

Headache 2019; (59(9)):1448-1467 doi:10.1111/head.13657.

Longitudinal Neuroimaging over 30 Days: Temporal Characteristics of Migraine.

Schulte LH, Mehnert J, May A

Annals of neurology 2020; (87(4)):646-651 doi:10.1002/ana.25697.

Extra-Axial Inflammatory Signal in Parameninges in Migraine with Visual Aura.

Hadjikhani N, Albrecht DS, Mainero C, et al.

Annals of neurology 2020; (87(6)):939-949 doi:10.1002/ana.25731.

Migraine Aura: Updates in Pathophysiology and Management.

Lai J, Dilli E

Current neurology and neuroscience reports 2020; (20(6)):17 doi:10.1007/s11910-020-01037-3.

Emerging evidence for noninvasive vagus nerve stimulation for the treatment of vestibular migraine.

Beh SC

Expert review of neurotherapeutics 2020; (20(10)):991-993 doi:10.1080/14737175.2020.1806060.

Comparing prospective headache diary and retrospective four-week headache questionnaire over 20 weeks: Secondary data analysis from a randomized controlled trial.

Miller VE, Faurot KR, Palssson OS, et al.

Cephalalgia : an international journal of headache 2020; (40(13)):1523-1531 doi:10.1177/0333102420949180.

Progressive Ataxia with Hemiplegic Migraines: a Phenotype of CACNA1A Missense Mutations, Not CAG Repeat Expansions.

Duque KR, Marsili L, Sturchio A, et al.

Cerebellum (London, England) 2021; (20(1)):134-139 doi:10.1007/s12311-020-01185-9.

A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.

Chen ST, Wu JW

Progress in brain research 2020; (255()):123-142 doi:10.1016/bs.pbr.2020.05.012.

[Clinical characteristics analysis of patients with Meniere's disease and vestibular migraine].

Chen Y, Sun H, Zhang Q, et al.

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery 2020; (34(9)):820-823 doi:10.13201/j.issn.2096-7993.2020.09.012.

Are some patient-perceived migraine triggers simply early manifestations of the attack?

Karsan N, Bose P, Newman J, Goadsby PJ

Journal of neurology 2021; (268(5)):1885-1893 doi:10.1007/s00415-020-10344-1.

Chronic migraine: Genetics or environment?

Chalmer MA, Rasmussen AH, , et al.

European journal of neurology 2021; (28(5)):1726-1736 doi:10.1111/ene.14724.

Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.

Ament M, Day K, Stauffer VL, et al.

The journal of headache and pain 2021; (22(1)):6 doi:10.1186/s10194-021-01215-9.

Can you have a migraine aura without knowing it?

Hadjikhani N, Vincent M

Current opinion in neurology 2021; (34(3)):350-355 doi:10.1097/WCO.0000000000000924.

Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache.

Pensato U, Baraldi C, Favoni V, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(2)):1273-1280 doi:10.1007/s10072-021-05426-5.

Determining the Evolution of Headache Among Regular Users of a Daily Electronic Diary via a Smartphone App: Observational Study.

Raffaelli B, Mecklenburg J, Overeem LH, et al.

JMIR mHealth and uHealth 2021; (9(7)):e26401 doi:10.2196/26401.

The chronobiology of migraine: a systematic review.

Poulsen AH, Younis S, Thuraiaiyah J, Ashina M

The journal of headache and pain 2021; (22(1)):76 doi:10.1186/s10194-021-01276-w.

CGRP and CGRP-Receptor as Targets of Migraine Therapy: Brain Prize-2021.

Tajti J, Szok D, Nyári A, Vécsei L

CNS & neurological disorders drug targets 2022; (21(6)):460-478 doi:10.2174/1871527320666211011110307.

Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families.

Häppölä P, Gormley P, Nuottamo ME, et al.

Cephalalgia : an international journal of headache 2022; (42(4-5)):345-356 doi:10.1177/03331024211045651.

Next-generation sequencing identified a novel CACNA1A I1379F variant in a familial hemiplegic migraine type 1 pedigree: A case report.

Luan H, Zhang L, Zhang S, Zhang M

Medicine 2021; (100(51)):e28141 doi:10.1097/MD.0000000000028141.

Dural Immune Cells, CGRP, and Migraine.

Balcziak LK, Russo AF

Frontiers in neurology 2022; (13()):874193 doi:10.3389/fneur.2022.874193.

The diagnostic values of red flags in pediatric patients with headache.

Park EG, Yoo IH

Brain & development 2022; (44(8)):512-519 doi:10.1016/j.braindev.2022.04.008.

Type and Severity of Migraine Determines Risk of Atrial Fibrillation in Women.

Rhee TM, Choi EK, Han KD, et al.

Frontiers in cardiovascular medicine 2022; (9()):910225 doi:10.3389/fcvm.2022.910225.

Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience.

Altamura C, Brunelli N, Marcosano M, et al.

Journal of neurology 2022; (269(11)):5848-5857 doi:10.1007/s00415-022-11226-4.

Vestibular migraine.

Silva VPR, Castro LHM, Calderaro M

Arquivos de neuro-psiquiatria 2022; (80(5 Suppl 1)):232-237 doi:10.1590/0004-282X-ANP-2022-S111.

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline.

Diener HC, Kropp P, Dresler T, et al.

Neurological research and practice 2022; (4(1)):37 doi:10.1186/s42466-022-00200-0.

The brain structure and function abnormalities of migraineurs: A systematic review and neuroimaging meta-analysis.

Chen ZH, Cui YL, Sun JT, et al.

Frontiers in neurology 2022; (13()):1022793 doi:10.3389/fneur.2022.1022793.

Magnetic resonance spectroscopy studies in migraine.

Nikolova S, Schwedt TJ

Neurobiology of pain (Cambridge, Mass.) 2022; (12()):100102 doi:10.1016/j.ynpai.2022.100102.

Preclinical Studies of Posttraumatic Headache and the Potential Therapeutics.

Tanaka M, Zhang Y

Cells 2022; (12(1)) doi:10.3390/cells12010155.

An investigation of the effects of connective tissue massage in women with migraine: A controlled clinical trial.

Toprak Celenay S, Coban O, Mete O, Karahan N

Journal of bodywork and movement therapies 2023; (33()):112-119 doi:10.1016/j.jbmt.2022.09.008.

Changes of migraine aura with advancing age of patients.

Scutelnic A, Drangova H, Klein A, et al.

The journal of headache and pain 2023; (24(1)):100 doi:10.1186/s10194-023-01642-w.

Neuroimaging in the pre-ictal or premonitory phase of migraine: a narrative review.

Karsan N, Goadsby PJ

The journal of headache and pain 2023; (24(1)):106 doi:10.1186/s10194-023-01617-x.

Estimating quality of life in a headache referral population based on Migraine disability assessment scale and headache impact test.

Togha M, Seyed-Ahadi M, Jafari E, et al.

Current journal of neurology 2020; (19(2)):76-84 doi:10.18502/cjn.v19i2.4944.

Association between risk factors and migraine in Pakistani females.

Razzak N, Khan H, Tariq H, Aslam M

BMC women's health 2023; (23(1)):642 doi:10.1186/s12905-023-02810-5.

Migraine prodromes and migraine triggers.

Fischer-Schulte LH, Peng KP

Handbook of clinical neurology 2023; (198()):135-148 doi:10.1016/B978-0-12-823356-6.00014-7.

A new neuromodulation method in chronic migraine; non-ınvasive pulsed radiofrequency, a single-blinded, randomised, controlled trial.

Perdecioğlu GRG, Ateş MP, Yürük D, et al.

Irish journal of medical science 2024; (193(3)):1487-1493 doi:10.1007/s11845-023-03598-x.

Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.

Barbanti P, Aurilia C, Egeo G, et al.

Journal of neurology 2024; (271(5)):2434-2443 doi:10.1007/s00415-023-12103-4.

Nutraceuticals in migraine.

Rajapakse T, Gantenbein AR

Handbook of clinical neurology 2024; (199()):125-144 doi:10.1016/B978-0-12-823357-3.00001-X.

Hemiplegic migraine.

de Boer I, Hansen JM, Terwindt GM

Handbook of clinical neurology 2024; (199()):353-365 doi:10.1016/B978-0-12-823357-3.00015-X.

The evolving concept of multimorbidity and migraine.

Altamura C, Coppola G, Vernieri F

Handbook of clinical neurology 2024; (199()):535-566 doi:10.1016/B978-0-12-823357-3.00014-8.

Preventive treatment of migraine: Non-specific oral agents.

Tronvik E, Giri S, Young W

Handbook of clinical neurology 2024; (199()):67-86 doi:10.1016/B978-0-12-823357-3.00009-4.

Headache providers' perspectives of headache diaries in the era of increasing technology use: a qualitative study.

Minen M, George A, Lebowitz N, et al.

Frontiers in neurology 2023; (14()):1270555 doi:10.3389/fneur.2023.1270555.

Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update.

Charles AC, Digre KB, Goadsby PJ, et al.

Headache 2024; (64(4)):333-341 doi:10.1111/head.14692.

Predictive performance of the common red flags in emergency department headache patients: a HEAD and HEAD-Colombia study.

Chu K, Kelly AM, Kuan WS, et al.

Emergency medicine journal : EMJ 2024; (41(6)):368-375 doi:10.1136/emermed-2023-213461.

Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis.

Scheffler A, Basten J, Menzel L, et al.

The journal of headache and pain 2024; (25(1)):109 doi:10.1186/s10194-024-01813-3.

Practical Experience with the Use of Electronic Headache Diaries and Video Consultations in Migraine Care from a Longitudinal Cohort Study.

van der Arend BWH, Holwerda LJ, Verhagen IE, et al.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association 2024; (30(11)):2696-2703 doi:10.1089/tmj.2024.0105.

The Brain, the Eating Plate, and the Gut Microbiome: Partners in Migraine Pathogenesis.

Gazerani P, Papetti L, Dalkara T, et al.

Nutrients 2024; (16(14)) doi:10.3390/nu16142222.

Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis.

Karlsson WK, Ostinelli EG, Zhuang ZA, et al.

BMJ (Clinical research ed.) 2024; (386()):e080107 doi:10.1136/bmj-2024-080107.

A Case Report of Hemiplegic Migraine with Mutation in the ATP1A2 Gene.

Guan DM, Shan YZ, Zhao HT, et al.

Pharmacogenomics and personalized medicine 2024; (17()):437-442 doi:10.2147/PGPM.S473335.

Insights from triggers and prodromal symptoms on how migraine attacks start: The threshold hypothesis.

Sebastianelli G, Atalar AÇ, Cetta I, et al.

Cephalalgia : an international journal of headache 2024; (44(10)):3331024241287224 doi:10.1177/03331024241287224.

Molecular and Cellular Neurobiology of Spreading Depolarization/Depression and Migraine: A Narrative Review.

Kitamura E, Imai N

International journal of molecular sciences 2024; (25(20)) doi:10.3390/ijms252011163.

The incremental burden and healthcare resource utilization among people with migraine in Europe: Insights from the 2020 European National Health and Wellness Survey.

Gendolla A, Brown JD, Mercadante AR, et al.

Cephalalgia : an international journal of headache 2024; (44(12)):3331024241276415 doi:10.1177/03331024241276415.

Assessment of Relationship Between Dietary Factors, Socioeconomic Factors, Behavioral Factors, Physical Measurement, and Risk of Migraine: A Univariable and Multivariable Mendelian Randomization Study.

Zhang Y, Liu H, Chen X, Dong D

The Clinical journal of pain 2025; (41(2)) doi:10.1097/AJP.0000000000001268.

Prevalence, Treatment, and Unmet Needs of Migraine in the Middle East: A Systematic Review.

Alsaadi T, Al Madani A, Alhatou M, et al.

Pain and therapy 2025; (14(1)):145-183 doi:10.1007/s40122-024-00686-3.

Is there a difference in the results of the video head impulse test in patients with a nosological diagnosis of Ménière's Disease and Vestibular Migraine?

Aguiar MCF, Nascimento GFFD, Costa APM, et al.

CoDAS 2025; (37(1)):e20230359 doi:10.1590/2317-1782/e20230359pt.

Acute Headache Diagnosis and Management.

Parikh SK

The Medical clinics of North America 2025; (109(2)):529-541 doi:10.1016/j.mcna.2024.10.004.

Uncovering longitudinal changes in the brain functional connectome along the migraine cycle: a multilevel clinical connectome fingerprinting framework.

Esteves I, Fouto AR, Ruiz-Tagle A, et al.

The journal of headache and pain 2025; (26(1)):29 doi:10.1186/s10194-025-01969-6.

[The headache questionnaire of the German Migraine and Headache Society (DMKG) : A new tool to improve headache care].

Ruscheweyh R, Gaul C, Dresler T, et al.

Schmerz (Berlin, Germany) 2025; (39(3)):169-176 doi:10.1007/s00482-025-00870-0.

CROATIAN GUIDELINES FOR SPECIFIC PREVENTIVE TREATMENT OF MIGRAINE WITH MONOCLONAL ANTIBODIES TARGETING CALCITONIN GENE-RELATED PEPTIDE (CGRP) (EPTINEZUMAB, FREMANEZUMAB, AND GALCANEZUMAB) OR THE CGRP RECEPTOR (ERENUMAB).

Jančuljak D, Petravić D, Mahović Lakušić D, et al.

Acta clinica Croatica 2024; (63(2)):436-450 doi:10.20471/acc.2024.63.02.22.

Evaluating Migraine Trigger Surprisal: Associations with Migraine Activity.

Turner DP, Patel T, Caplis E, Houle TT

medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.04.23.25325821.

No additional benefit with detoxification strategies: A real world experience in 200 patients with chronic migraine and either simple or complex MOH treated with CGRP monoclonal antibodies.

Silvestro M, Orologio I, Sozio P, et al.

Cephalalgia : an international journal of headache 2025; (45(6)):3331024251329808 doi:10.1177/03331024251329808.

Comprehensive preventive treatments for episodic migraine: a systematic review of randomized clinical trials.

Vélez-Jiménez MK, Martínez-Mayorga AP, Rodriguez-Leyva I, et al.

Frontiers in neurology 2025; (16()):1611303 doi:10.3389/fneur.2025.1611303.

Overlap between perceived triggers, premonitory symptoms and symptom persistence across migraine phases: A REFORM study.

Thuraiaiyah J, Christensen RH, Al-Khazali HM, et al.

Cephalalgia : an international journal of headache 2025; (45(8)):3331024251364234 doi:10.1177/03331024251364234.

Comparative Analysis of Real-World Acute Prescription Migraine Therapy Outcomes: Insights from the HeAD-US Study.

Teichrow D, Khorsand B, Fanning KM, et al.

medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.09.18.25336093.

Migraine in monogenic disorders: Shedding light on new therapeutic targets.

Mascarella D, Zhuang ZA, Gliga O, et al.

Cephalalgia : an international journal of headache 2025; (45(10)):3331024251389241 doi:10.1177/03331024251389241.

Information-Theoretic Trigger Surprisal and Future Headache Activity.

Turner DP, Patel T, Caplis E, Houle TT

JAMA network open 2025; (8(11)):e2542944 doi:10.1001/jamanetworkopen.2025.42944.

Gepants: targeting the CGRP pathway for migraine relief.

Jakubowska B, Sowa-Kućma M

Frontiers in pharmacology 2025; (16()):1708226 doi:10.3389/fphar.2025.1708226.

Evoked potential studies in migraine: A systematic review of neurophysiological patterns across migraine subtypes.

Ulutas S, Özçelik EU, Dabó LG, et al.

Cephalalgia : an international journal of headache 2025; (45(12)):3331024251398792 doi:10.1177/03331024251398792.

The burden of high-frequency episodic migraine and chronic migraine in the population-based PopHEAD study.

Engstrand H, Argren MB, Zwart JA, et al.

Cephalalgia : an international journal of headache 2025; (45(12)):3331024251406103 doi:10.1177/03331024251406103.

Reduced Frequency of Prolonged Sporadic Hemiplegic Migraine Attacks Following Fremanezumab Treatment-A Case Report.

Hotz JF, Kaindl L, Krebs S, et al.

European journal of neurology 2026; (33(2)):e70514 doi:10.1111/ene.70514.

[Hemiplegic migraine: from historical perspectives to current management].

Shibata M, Saigoh K, Danno D, et al.

Rinsho shinkeigaku = Clinical neurology 2026; (66(6)):375-383 doi:10.5692/clinicalneurol.cn-002244.

High-altitude headache: Insights into pathophysiology and potential treatment implications.

Falla M, Frank F, Strapazzon G, Lawley J

The Journal of physiology 2026; doi:10.1113/JP289704.